Skip to main content
Log in

Subclinical hypothyroidism: The state of the art

  • Short Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Subclinical hypothyroidism (SH) is a common clinical problem, particularly in adulthood and the elderly. Its prevalence is conditioned by several etiological and risk factors. The highest age- and sex-specific rates are in women over 60. SH may be associated with manifestations of mild thyroid failure, which may reverse under levothyroxine (L-T4) therapy. The risk of progression to overt hypothyroidism is distinctly higher in cases with underlying thyroid disease. A population routine screening is not generally recommended, but screening is encouraged in high-risk groups. L-T4 therapy may be indicated in subjects with TSH levels which are repeatedly and consistently elevated (>10 μIU/ml) and may be considered in those with TSH ranging between 4.5–5.5 and 10 μIU/ml, particularly if anti-thyroid antibodies are positive and/or hypothyroid symptoms are present. Treatment should be based, at least initially, on L-T4 low doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, The American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005, 90: 581–5.

    Article  PubMed  CAS  Google Scholar 

  2. Surks MI, Ortiz E, Daniels GhH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228–38.

    Article  PubMed  CAS  Google Scholar 

  3. Ayala A, Danese MD, Ladenson PW. When to treat mild hypothyroidism. Endocrinol Metab Clin North Am 2000, 29: 399–415.

    Article  PubMed  CAS  Google Scholar 

  4. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med 2001, 345: 260–5.

    Article  CAS  Google Scholar 

  5. Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician 2005, 72: 1517–24.

    PubMed  Google Scholar 

  6. Ringel MD, Mazzaferri EL. Subclinical thyroid dysfunction — can there be a consensus about the consensus? J Clin Endocrinol Metab 2005, 90: 588–90.

    Article  PubMed  CAS  Google Scholar 

  7. Surks MI. Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab 2005, 90: 586–7.

    Article  CAS  Google Scholar 

  8. Surks MI, Goswami G, Daniels GH. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 2005, 90: 5489–96.

    Article  PubMed  CAS  Google Scholar 

  9. Niedziela M. Subclinical hypothyroidism: dilemmas in the treatment of children. J Endocrinol Invest 2007, 30: 529–31.

    Article  PubMed  CAS  Google Scholar 

  10. Huber G, Staub JJ, Meier C, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 2002, 87: 3221–6.

    Article  PubMed  CAS  Google Scholar 

  11. Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 2001, 86: 4591–9.

    Article  PubMed  CAS  Google Scholar 

  12. McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab 2001, 86: 4585–90.

    Article  PubMed  CAS  Google Scholar 

  13. Canaris GJ, Manowitz NR, Mayor GM, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160: 526–34.

    Article  PubMed  CAS  Google Scholar 

  14. Cetinkaya E, Aslan AT, Vidinlisan S, Ocal G. Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr Int 2003, 45: 534–7.

    Article  PubMed  CAS  Google Scholar 

  15. Paoli-Valeri, M, Mamán-Alvarado D, Jiménez-López V, Arias-Ferreira A, Bianchi G, Arata-Ballabarba G. Frequency of subclinical hypothyroidism among healthy children and those with neurological conditions in the state of Mérida, Venezuela. Invest Clin 2003, 44: 209–18.

    PubMed  Google Scholar 

  16. Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr 2006, 6: 12.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Calaciura F, Motta MR, Miscio G, et al. Subclinical hypothyroidism in early childhood: a frequent outcome of transient neonatal hyperthyrotropinemia. J Clin Endocrinol Metab 2002, 87: 3209–14.

    Article  PubMed  CAS  Google Scholar 

  18. Camilot M, Teofoli F, Gandini A, et al. Thyrotropin receptor gene mutations and TSH resistance: variable expressivity in the heterozygotes. Clin Endocrinol (Oxf) 2005, 63: 146–51.

    Article  CAS  Google Scholar 

  19. Adlin V. Subclinical hypothyroidism: deciding when to treat. Am Fam Physician 1998, 57: 776–80.

    PubMed  CAS  Google Scholar 

  20. Zulewski H, Müller B, Exer P, Miserez AR, Staub JJ. Estimation of tissue hypothyroidism by e new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 1997, 82: 771–6.

    PubMed  CAS  Google Scholar 

  21. Lindeman RD, Schade DS, LaRue A, et al. Subclinical hypothyroidism in a biethnic, urban community. J Am Geriatr Soc 1999, 47: 703–9.

    PubMed  CAS  Google Scholar 

  22. Aijaz NJ, Flaherty EM, Preston T, Bracken SS, Lane AH, Wilson TA. Nurocognitive function in children with compensated hypothyroidism: lack of short term effects on or off thyroxin. BMC Endocr Disord 2006, 6: 2.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  23. Meier C, Staub JJ, Roth CB, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001, 86: 4860–6.

    Article  PubMed  CAS  Google Scholar 

  24. Kosar F, Sahin I, Turan N, Topal E, Aksoy Y, Taskapan C. Evaluation of right and left ventricular function using pulsed-wave tissue Doppler echocardiography in patients with subclinical hypothyroidism. J Endocrinol Invest 2005, 28: 704–10.

    Article  PubMed  CAS  Google Scholar 

  25. Díez JJ, Iglesias P, Burman KD. Spontaneous normalization of thyrotropin concentrations in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 2005, 90: 4124–7.

    Article  PubMed  CAS  Google Scholar 

  26. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991, 34: 77–83.

    Article  CAS  Google Scholar 

  27. Kabadi UM. ‘Subclinical hypothyroidism’. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 1993, 153: 957–61.

    CAS  Google Scholar 

  28. Surks MI, Ocampo E. Subclinical thyroid disease. Am J Med 1996, 100: 217–23.

    Article  PubMed  CAS  Google Scholar 

  29. Radetti G, Gottardi E, Bona G, Corrias A, Salardi S, Loche S; Study Group for Thyroid Diseases of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED). The natural history of euthyroid Hashimoto’s thyroiditis in children. J Pediatr 2006, 149: 827–32.

    Article  PubMed  Google Scholar 

  30. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43: 55–68.

    Article  CAS  Google Scholar 

  31. Moore DC. Natural course of ‘subclinical’ hypothyroidism in childhood and adolescence. Arch Pediatr Adolesc Med 1996, 150: 293–7.

    Article  PubMed  CAS  Google Scholar 

  32. Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996, 276: 285–92.

    Article  PubMed  CAS  Google Scholar 

  33. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999, 341: 549–55.

    Article  PubMed  CAS  Google Scholar 

  34. Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 2000, 7: 127–30.

    Article  PubMed  CAS  Google Scholar 

  35. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 37. August 2002. (Replaces Practice Bulletin Number 32, November 2001). Thyroid disease in pregnancy. Obstet Gynecol 2002, 100: 387–96.

    Article  Google Scholar 

  36. U.S. Preventive Services Task Force. Screening for thyroid disease: recommendation statement. Ann Intern Med 2004, 140: 125–7.

    Article  Google Scholar 

  37. American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002, 8: 457–69.

    Google Scholar 

  38. Diamond FB, Bercu BB. Normative laboratory results. In: Pescovitz OH, Eugster EA eds. Pediatric endocrinology: mechanisms, manifestations and management. Lippincott Williams & Wilkins 2004, 780–825.

    Google Scholar 

  39. Ito M, Arishima T, Kudo T, et al. Effect of L-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab 2006 Dec 5 (Epub ahead of print).

  40. Nyström E, Caidahl K, Fager G, Wikkelsö C, Lundberg PA, Lindstedt G. A double-blind cross-over 12-month study of L-thyroxine treatment of women with “subclinical” hypothyroidism. Clin Endocrinol (Oxf) 1988, 29: 63–75.

    Article  Google Scholar 

  41. Jaeschke R, Guyatt G, Gerstein H, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996, 11: 744–9.

    Article  PubMed  CAS  Google Scholar 

  42. Monzani F, Del Guerra P, Caraccio N, et al. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Investig 1993, 71: 367–71.

    PubMed  CAS  Google Scholar 

  43. Baldini IM, Vita A, Mauri MC, et al. Psychopathological and cognitive features in subclinical hypothyroidism. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21: 925–35.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. De Luca MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arrigo, T., Wasniewska, M., Crisafulli, G. et al. Subclinical hypothyroidism: The state of the art. J Endocrinol Invest 31, 79–84 (2008). https://doi.org/10.1007/BF03345571

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345571

En]Keywords

Navigation